The chromatin guardian ATRX is a strong prognostic biomarker in melanoma.

ABSTRACT:

SUBMITTER: Frei CA 

PROVIDER: S-EPMC12789088 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature